Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Pharmacol ; 12: 684550, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34054560

RESUMO

Background: Vitamin E has been increasingly used to prevent chemotherapy-induced peripheral neuropathy (CIPN) in recent years. However, it is still unclear whether vitamin E can effectively prevent CIPN. Methods: We searched all clinical studies in the Embase, Cochrane Library, Clinicaltrials.gov, and PubMed databases from inception to December 2020. We performed a meta-analysis of 9 randomized controlled trials (RCTs) with 486 patients that compared the vitamin E group with the control group. Outcomes of the study were incidence of all-grade CIPN, incidence of severe CIPN, and the total neuropathy scores (TNS). Random effect models were used to make the meta-analysis results more cautious. Results: Notably, vitamin E significantly reduced the incidence of all-grade CIPN (overall risk ratio (RR) = 0.55, 95% CI: 0.36, 0.85, I2 = 77.3%, p = 0.007), and TNS (overall standard mean difference (SMD) = -0.64, 95% CI: -1.03, -0.25, I2 = 42.7%, p = 0.001). However, the results of the subgroup analysis, which included only double-blind RCTs, suggested that vitamin E did not significantly reduce the incidence of all-grade CIPN (overall RR = 0.52, 95% CI: 0.07, 4.06, I2 = 77.5%, p = 0.531). Moreover, there was no significant difference in the incidence of severe CIPN between these two arms (p = 0.440). Conclusion: The results of our meta-analysis suggests that vitamin E has a beneficial effect on the incidence and symptoms of CIPN. However, routine prophylactic use of vitamin E is still not recommended. Moreover, more high-quality double-blind RCTs are needed to further validate the effects of vitamin E in prevention of CIPN.

2.
Cell Metab ; 30(2): 319-328.e8, 2019 08 06.
Artigo em Inglês | MEDLINE | ID: mdl-31230984

RESUMO

Asprosin is a fasting-induced hormone that promotes glucose production in the liver and stimulates appetite in the hypothalamus by activating the cAMP signaling pathway via an unknown G protein-coupled receptor (GPCR). However, the bona fide receptor of Asprosin is unclear. Here, we have identified that the olfactory receptor OLFR734 acts as a receptor of Asprosin to modulate hepatic glucose production. Olfr734 knockout mice show a blunted response to Asprosin, including attenuated cAMP levels and hepatic glucose production, and improved insulin sensitivity. As Olfr734 deficiency dramatically attenuates both fasting and high-fat-diet-induced glucose production, our results demonstrate a critical role of OLFR734 as a receptor of Asprosin to maintain glucose homeostasis during fasting and in obesity.


Assuntos
Glucose/metabolismo , Receptores Odorantes/metabolismo , Células 3T3-L1 , Animais , Células Cultivadas , Células HEK293 , Células Hep G2 , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Transgênicos , Receptores Odorantes/deficiência
3.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 44(1): 49-53, 2015 01.
Artigo em Chinês | MEDLINE | ID: mdl-25851975

RESUMO

OBJECTIVE: To investigate the effect of ethanol extracts from Dioscoreae Nipponicae Rhizoma on hyperuricemic mice. METHODS: The hyperuricemia was induced by gavage of hypoxanthine and subcutaneous injection of potassium oxonate (model A) or subcutaneous injection of uric acid (model B) in ICR male mice. The mice in ethanol extracts groups were administrated with Dioscoreae Nipponicae Rhizoma ethanol extracts 5.4 g/kg by gavage, the positive control groups were given with 10 mg/ml allopurinol or 5 mg/ml benzbromarone by gavage, respectively. The plasma uric acid levels were measured by using HPLC. RESULTS: The plasma uric acid levels of model group, control group and ethanol extract group in model A mice were (40.03±27.24), (4.08±1.47) and (18.10±8.87) g/mL (compared with model group, P <0.05), respectively. The plasma uric acid levels of model group, control group and ethanol extract group in model B mice were (18.57±3.83), (4.29±2.36) and (15.36±2.71) g/mL (compared with model group, P <0.05), respectively. CONCLUSION: The ethanol extracts from Dioscoreae Nipponicae Rhizoma have certain hypouricemic effect in hyperuricemic mice induced by hypoxanthine and potassium oxonate or by uric acid.


Assuntos
Dioscorea/química , Hiperuricemia/tratamento farmacológico , Extratos Vegetais/farmacologia , Animais , Modelos Animais de Doenças , Hiperuricemia/induzido quimicamente , Masculino , Camundongos , Camundongos Endogâmicos ICR , Raízes de Plantas/química , Ácido Úrico/sangue
4.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 40(4): 391-4, 2011 07.
Artigo em Chinês | MEDLINE | ID: mdl-21845752

RESUMO

OBJECTIVE: To investigate the effect of Jiangbaiweiyan tablet, a Chinese medicine compound composed of Alpinta Officinarum, Cyperus Rotundus, Bulbus Lilii and Rlindera Strychnifolia, on ethanol-induced gastric mucosa injury in rats. METHODS: Acute gastric ulcer was induced in rats with absolute ethyl alcohol. The ulcer index was used to evaluate the extent of the gastric mucosa injury. RESULTS: The ulcer indexes of the model group, the mid-dose (1.08 g x kg(-1) x d-(-1)1) and high-dose (2.16 g x kg(-1) x d-(-1)) of Jiangbaiweiyan tablet groups were 141.58±47.43, 24.83±23.04 and 2.12±2.58, respectively (P<0.01). CONCLUSION: Jiangbaiweiyan tablet has protective effects on ethanol-induced gastric mucosa injury in rats, which may be related to anti-oxidation and enhancing tissue regeneration capacity.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Etanol/toxicidade , Mucosa Gástrica/efeitos dos fármacos , Úlcera Gástrica/prevenção & controle , Animais , Modelos Animais de Doenças , Feminino , Mucosa Gástrica/patologia , Ratos , Ratos Sprague-Dawley , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/patologia , Comprimidos
5.
Eur J Pharm Biopharm ; 70(2): 462-6, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18632257

RESUMO

A simple three-descriptor model to predict blood-brain barrier is derived from a training set of 78 compounds: logBB=-9.880 x 10(-6)M(W)(2)+7.339 x 10(-3)M(W)-0.2268n(pol)-0.1143 (n=78, r(2)=0.74), where logBB is the logarithm of the ratio of the steady-state concentration of the compound in the brain to concentration in the blood, M(W) is the molecular weight, n(pol) is the number of polar atoms (oxygen, nitrogen, and attached hydrogen), n is the number of compounds, and r is the correlation coefficient. The model is validated through use of leave-one-out procedure and an external test set (25 compounds). The model is suitable for the rapid prediction of the blood-brain barrier penetration of drug candidates because of its predictive ability and simplicity.


Assuntos
Barreira Hematoencefálica , Modelos Biológicos , Modelos Estatísticos , Peso Molecular , Permeabilidade , Valor Preditivo dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...